Sheela Foam Ltd

- No explicit mention of any current or immediate future fundraising through debt or equity in the transcript. - The company has recently repaid around INR 400 crores of debt using cash from asset sales and prior capital raised during the Kurlon acquisition. - Net debt levels currently stand between INR 600-650 crores consolidated (India less than INR 300 crores, overseas around INR 325-350 crores). - The management indicates stable financials with no major new CapEx plans, implying limited need for fresh funds. - Discussions on dividend and buyback options are ongoing but no definitive decision on raising funds. - Overall, the focus appears to be on deleveraging and using operational cash flow rather than raising new debt or equity at this stage.

- Maintenance CapEx expected to be around INR 30-40 crores per year. - Total anticipated CapEx including efficiency and debottlenecking CapEx is around INR 125 crores (INR 100 crores in India and INR 25 crores overseas). - No major new CapEx plans currently; focus is on debottlenecking and efficiency improvements with payback periods of 1.5-2 years. - Investment in a new machinery (ordered from overseas) related to synergy realization expected to be installed by mid of the current quarter; full benefits expected in next financial year. - Continued investment in Furlenco: recently infused INR 30 crores alongside new investors to support its growth to INR 500-550 crores topline. - Strategic capital-efficient expansion of Furlenco's offline presence through partnership leveraging Sheela Foam’s retail network. - No immediate plans announced for buyback, but the board is reviewing dividend and buyback policies.

- The company targets a medium-term revenue growth of around 15%, aiming to increase from the current approximately 7% growth rate. - Volume growth is expected to align closer with value growth, particularly in the mattress and foam segments, aided by price adjustments. - Expansion in showroom formats such as Sleepwell and Kurlon brands is a key strategy to drive growth, with plans to add around 700 new exclusive brand outlets (EBOs) for the year. - Growth in the international business is expected to be moderate, around 5-6%, with cost control measures to maintain profitability. - The focus remains on balancing price hikes with market acceptance to sustain volume growth without significant drop-off. - New synergies and improved cost structures post-Kurlon acquisition support enhanced margins alongside growth initiatives. - Growth is expected to continue across offline, e-commerce, and unorganized to organized (U2O) segments, with brand.com witnessing over 50% growth recently.

- Sheela Foams aims for a long-term revenue growth target of around 15% per annum, with plans to transition from the current ~7% growth towards this medium-term target. - EBITDA margins are expected to improve progressively, targeting approximately 14-15% by FY28, moving up gradually from current levels around 10-11%. - Operating leverage benefits are anticipated with revenue growth, though cost flexibility allows scaling back expenses if growth slows. - Consolidated PAT is growing, supported by higher profitability and reduced interest costs due to debt repayment. - Cash PAT stood at INR 209 crores for 9 months FY26, with consistent cash generation expected. - The company expects positive additions to revenue and profitability post recent price hikes in raw materials and finished goods. - Overseas operations aim to sustain EBITDA margins at around 12%, slightly above the current ~10%. - The management remains cautiously optimistic but refrains from committing to exact quarterly targets.

- The transcript does not explicitly mention the current or expected order book or pending orders for Sheela Foams Limited. - There is no direct discussion or figures provided related to order book status during the Q3FY26 earnings call. - The focus in the call is more on revenue growth, margin outlook, expansion strategies, pricing, and market conditions. - Investors and analysts mainly discussed financial performance, growth outlook, cost structure, and market expansion. - No specific data or guidance on order book or pending orders is disclosed in the provided pages of the transcript.